Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
about
Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV diseaseThe aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivoLive-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine DesignNew insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus.A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.
P2860
Q35070176-3676B723-40CE-4C61-9BC5-7961A9B03241Q35111071-23B2A309-37D6-4DEE-A8DE-63C55D12CA83Q35115588-3209CBEF-9453-4ADA-BBA9-CE0A0DE469EBQ35973617-72768CF4-F2D8-442F-8344-B9780E01A9DEQ36086315-8845DE55-B3AC-4F6D-97EE-5FB7D9A9217EQ37347267-67DA2FFF-2A77-4645-A9C6-5CB003CE69CEQ37729137-BCFEC3B3-5FFA-40F0-804B-AC7FD6ECB9FCQ38539476-3B206482-C626-44A2-BD58-DE3C26EE8B22Q39362187-093EA68B-B3C4-43B5-AA1E-88860E24D6E0Q40072947-26B1376F-FA09-41DC-BE0D-967A870AECACQ40187606-668DE43B-BFDD-4C16-A769-EC84949A8F2AQ40312271-A9B07AE4-DE19-47B6-BA6C-C90CB3CF81C4Q47555408-740C819F-B2BC-49B2-B423-6E05607B75FA
P2860
Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chimeric bovine/human parainfl ...... tection against RSV infection.
@en
Chimeric bovine/human parainfl ...... tection against RSV infection.
@nl
type
label
Chimeric bovine/human parainfl ...... tection against RSV infection.
@en
Chimeric bovine/human parainfl ...... tection against RSV infection.
@nl
prefLabel
Chimeric bovine/human parainfl ...... tection against RSV infection.
@en
Chimeric bovine/human parainfl ...... tection against RSV infection.
@nl
P2093
P2860
P356
P1433
P1476
Chimeric bovine/human parainfl ...... otection against RSV infection
@en
P2093
Anne Schaap-Nutt
Emerito Amaro-Carambot
Lijuan Yang
Natalie Mackow
Peter L Collins
Shirin Munir
Sonja Surman
Ursula J Buchholz
P2860
P304
P356
10.1128/JVI.03481-13
P407
P50
P577
2014-01-29T00:00:00Z